Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Lily Chiu"'
Publikováno v:
Global Medical Genetics, Vol 08, Iss 02, Pp 062-068 (2021)
Introduction A robust genetic test for BRCA1 and BRCA2 genes is necessary for the diagnosis, prognosis, and treatment of patients with hereditary breast and ovarian cancer. We evaluated a commercial amplicon-based massively parallel sequencing (MPS)
Externí odkaz:
https://doaj.org/article/c62dd90a683b47af8bcf9b3e48d884ba
Autor:
Isaac KS Ng, Joanne Lee, Christopher Ng, Bustamin Kosmo, Lily Chiu, Elaine Seah, Michelle Meng Huang Mok, Karen Tan, Motomi Osato, Wee-Joo Chng, Benedict Yan, Lip Kun Tan
Publikováno v:
Biomarker Research, Vol 6, Iss 1, Pp 1-7 (2018)
Abstract Background Germline mutations in the RUNX1 transcription factor give rise to a rare autosomal dominant genetic condition classified under the entity: Familial Platelet Disorders with predisposition to Acute Myeloid Leukaemia (FPD/AML). While
Externí odkaz:
https://doaj.org/article/8c249a81b8d14b5089c05e46f981186b
Autor:
Chun K. Lee, Hong K. Lee, Tze P. Loh, Florence Y.L. Lai, Paul A. Tambyah, Lily Chiu, Evelyn S.C. Koay, Julian W. Tang
Publikováno v:
Emerging Infectious Diseases, Vol 17, Iss 2, Pp 287-290 (2011)
Mean viral loads for patients with pandemic (H1N1) 2009 were ≈1 log10 times lower than those for patients with seasonal influenza within the first week after symptom onset. Neither pandemic nor seasonal influenza viral loads correlated with clinica
Externí odkaz:
https://doaj.org/article/a64cf7bf977d46af9384b455e6f5c835
83
Flavobavterium ranacida,一種革蘭氏陰性菌,為台灣養殖牛蛙中最主要 的病原菌.其胞膜的主要磷脂質成份是 phosphatidylethanolamine (PE) 以及 lysophosphatidylethanolamine(lysoPE),分別佔磷脂質的 80.99%及19%,
Flavobavterium ranacida,一種革蘭氏陰性菌,為台灣養殖牛蛙中最主要 的病原菌.其胞膜的主要磷脂質成份是 phosphatidylethanolamine (PE) 以及 lysophosphatidylethanolamine(lysoPE),分別佔磷脂質的 80.99%及19%,
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/00922001980438076070
Publikováno v:
Global Medical Genetics, Vol 08, Iss 02, Pp 062-068 (2021)
Global Medical Genetics
Global Medical Genetics
Introduction A robust genetic test for BRCA1 and BRCA2 genes is necessary for the diagnosis, prognosis, and treatment of patients with hereditary breast and ovarian cancer. We evaluated a commercial amplicon-based massively parallel sequencing (MPS)
Autor:
Samah Al-Harbi, Nora Fayed, Jill I. Cameron, Maha Wakim, Lily Chiu, Saoirse Cameron, Douglas D. Fraser, Racquel Simpson, Karen Choong
Publikováno v:
Paediatrics Publications
Background Outcomes in pediatric critical care research are typically selected by the researcher. Objectives (1) To identify outcomes prioritized by patients and their families following a critical illness and (2) to determine the overlap between pat
Autor:
Evelyn Siew-Chuan Koay, Min En Nga, T. Loh, Samantha Peiling Yang, Siok Bee Chionh, Xueying Goh, Rajeev Parameswaran, Kee Yuan Ngiam, Jeffery Lum, Chwee Ming Lim, Lily Chiu
Publikováno v:
Clinical Otolaryngology. 44:114-123
Objective BRAF mutation is the commonest mutation seen in papillary thyroid cancer (PTC), but its prevalence and clinical significance vary across countries. We aim to evaluate the prevalence and clinico-pathological correlation of BRAF mutation in P
Autor:
H. Lee, Tracy Si-Yu Png, Guan Huei Lee, Cui Wen Chua, Lily Chiu, Falah Yusrina, Chun Kiat Lee, Mui Joo Khoo, Gabriel Yan, Benedict Yan
Publikováno v:
Journal of Virological Methods. 255:8-13
Background : Correct identification of infecting hepatitis C virus (HCV) genotype is helpful for targeted antiviral therapy. Objectives : Here, we compared the HCV genotyping performance of the cobas HCV GT assay against the Versant HCV Genotype 2.0
Autor:
Lily Chiu
Publikováno v:
Journal of Food and Drug Analysis. 28:697-698
Autor:
Wee Joo Chng, Christopher Ng, Chun Kiat Lee, Kenneth Hon Kim Ban, Jingxue Guo, Jianbiao Zhou, Bustamin Kosmo, H. Lee, Karen Tan, Tin Wee Tan, Sherry Ho, Mingxuan Lin, Peak-Ling Lee, Zhaojin Chen, Benedict Yan, Lily Chiu
Publikováno v:
Journal of Clinical Pathology. 71:522-531
AimThe presence of biallelic CEBPA mutations is a favourable prognostic feature in acute myeloid leukaemia (AML). CEBPA mutations are currently identified through conventional capillary sequencing (CCS). With the increasing adoption of next-generatio